PBIO - Pressure BioSciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
2.2000
-0.3000 (-12.00%)
At close: 3:44PM EST
Stock chart is not supported by your current browser
Previous Close2.5000
Open0.0000
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume4,487
Market Cap3.854M
Beta (3Y Monthly)1.88
PE Ratio (TTM)N/A
EPS (TTM)-15.29
Earnings DateMar 20, 2018 - Mar 26, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.57
Trade prices are not sourced from all markets
  • ACCESSWIREyesterday

    Major Cancer Research Center Reports Pressure BioSciences' PCT Platform Could Play Major Role in Improving Cancer Diagnosis and Treatment

    SOUTH EASTON, MA / ACCESSWIRE / December 18, 2018 / Pressure BioSciences, Inc. (PBIO) ("PBI" or the "Company") is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries. The Company today announced that a team of scientists from the Centre for the Proteome of Human Cancer ("ProCan”) has published a recommended, streamlined, proteomic sample preparation protocol built around PBI's Barocycler instrument system, designed to help optimize the identification and use of novel cancer biomarkers for the improved diagnosis and treatment of cancers.

  • ACCESSWIRE2 days ago

    Pressure BioSciences, Inc. to Host Business Update on Wednesday, December 19th at 4:30 PM EST

    Update to Include Discussions on Recent Progress, Accomplishments, and Enhancements in All Three Platform Technologies; Commercialization and Strategic Partnership Efforts; Personnel Changes; and Q42018 ...

  • ACCESSWIRE21 days ago

    Pressure BioSciences Expands on Recent Achievement of Major Development Milestones in Ultra Shear Technology for Diverse High Value Products, Including CBD Oil

    SOUTH EASTON, MA / ACCESSWIRE / November 28, 2018 / Pressure BioSciences, Inc. (PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that Richard T. Schumacher, President and CEO, was interviewed by broadcast journalist Christine Corrado of Proactive Investors, a leading multi-media news organization, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt, and London. Ultra Shear Technology ("UST"), the Company's proprietary processing method, uniquely combines ultra high pressure with intense shearing forces to potentially create a wide range of high value product innovations for multiple major consumer and industrial markets.

  • ACCESSWIRE29 days ago

    Pressure BioSciences Joins Uptick Newswire's Stock Day Podcast to Share the Achievement of Another Important Milestone in the Development of Its Proprietary Ultra Shear Technology Platform

    SOUTH EASTON, MA / ACCESSWIRE / November 20, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. The Company's President and CEO, Mr. Richard T. Schumacher, joined Stock Day's Mr. Everett Jolly to announce the achievement of yet another important milestone in the advancement of its proprietary Ultra Shear Technology (UST) platform and commercialization program. Mr. Jolly began the interview by commenting that Mr. Schumacher must have some very exciting news to share, as he had appeared on the Stock Day Podcast just ten days earlier.

  • ACCESSWIRElast month

    Pressure BioSciences Achieves Second Major Milestone in the Development of Its Ultra Shear Technology Platform

    SOUTH EASTON, MA / ACCESSWIRE / November 15, 2018 / Pressure BioSciences, Inc. (PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced it has achieved its second major milestone in the development of its proprietary Ultra Shear Technology ("UST") platform and commercialization program. On November 9th, the Company announced it had completed development of the first working prototype for the UST System, thereby achieving its initial major milestone for the program. Concurrently, the Company disclosed that the second milestone would be the development of a method to make water soluble oils using the first working prototype system.

  • ACCESSWIRElast month

    Pressure BioSciences, Inc. Reports Third Quarter and YTD 2018 Financial Results and Provides Business Update

    Significant Operating Loss Decrease, Initial Revenue from New Scientific Services Group, and Accelerated Development of Ultra Shear Technology Platfo rm Highlight Q3 and YTD Results SOUTH EASON, MA / ACCESSWIRE ...

  • ACCESSWIRElast month

    Pressure BioSciences Inc. Discusses an Exciting Addition to Its Management Team, Their Innovative Ultra Shear Technology, and How They Hope to Help Shape the Rapidly Growing CBD Oil Market on Uptick Newswire's Stock Day Podcast

    PHOENIX, AZ / ACCESSWIRE / November 14, 2018 / Pressure BioSciences Inc. (OTCQB: PBIO) (the "Company") is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry. The Company's President and CEO, Richard T. Schumacher, joined Stock Day's Everett Jolly to discuss a new addition to the PBI Team, their proprietary Ultra Shear Technology ("UST") platform, and their potential game-changing entre into the CBD Oil market. As the interview began, Mr. Jolly asked Mr. Schumacher about the announcement of Dr. Brad Young joining the company as Senior Vice President and Chief Commercial Operator.

  • ACCESSWIRElast month

    Pressure BioSciences, Inc. to Discuss Third Quarter 2018 Financial Results and Provide Business Update

    Conference Call Scheduled for Wednesday, November 14 th at 4:30 PM EST SOUTH EASTON, MA / ACCESSWIRE / November 14, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") ...

  • ACCESSWIRElast month

    Pressure BioSciences Achieves Major Milestone in the Development of its Ultra Shear Technology Program

    SOUTH EASTON, MA / ACCESSWIRE / November 9, 2018 / Pressure BioSciences, Inc. (PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that significant progress has been made in its development program for its proprietary Ultra Shear Technology ("UST") platform. UST utilizes ultra-high pressure to create intense, momentary liquid shearing forces at controlled temperatures resulting in a novel and continuous flow process for affordable and scalable homogenization of liquids, creams and gels. The UST platform creates very small (nano)-scale emulsion mixtures of fluids that otherwise do not mix, resulting in room-temperature stable homogenized products called nanoemulsions (suspensions of microscopic oil droplets in water).

  • ACCESSWIRElast month

    Bradford A. Young, Ph.D., MBA Joins Pressure BioSciences as Chief Commercial Officer

    SOUTH EASTON, MA / ACCESSWIRE / November 7, 2018 / Pressure BioSciences, Inc. (PBIO) (''PBI'' or the ''Company''), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that Dr. Bradford A. Young has joined the Company as Sr. Vice President and Chief Commercial Officer (''CCO'') effective Monday, November 5, 2018. In this key new leadership position, Dr. Young is responsible for assessing multiple major new and divergent market opportunities, and for optimizing the commercialization priorities and strategy for the Company. Beyond strategic planning, Dr. Young will drive the execution of critical partnering and commercialization programs to build customer adoption and accelerate revenue growth.

  • ACCESSWIRE3 months ago

    Pressure BioSciences Accelerates Development of Novel Ultra Shear Technology Platform to Pursue Commercialization into Major New Markets

    Company's Commitment Includes Significant Buildout of Manufacturing Space, Accelerated Instrument & ApplicationsDevelopment, Staff Additions, New IP Development, and Expanded Partnership Negotiations SOUTH ...

  • GlobeNewswire3 months ago

    Pressure BioSciences Inc. Discusses New Instrument Release, Entry into the Worldwide Food Science Area, and their Innovative Ultra Shear Technology Platform on Uptick Newswire’s Stock Day Podcast

    Pressure BioSciences Inc. (OTCQB: PBIO) (the “Company”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry.  The Company’s President and CEO, Richard T. Schumacher, joined Stock Day’s Everett Jolly to discuss an exciting new instrument release, the recent featuring of their product line at the largest annual food science meeting in the world, and the continued development of their innovative and enabling Ultra Shear Technology (“UST”) platform.

  • ACCESSWIRE3 months ago

    Pressure BioSciences' Ultra High Pressure Instruments, Processing Methods, and Platform Technologies Prominently Featured at Leading Food Science Meeting

    SOUTH EASTON, MA / ACCESSWIRE / September 20, 2018 / Pressure BioSciences, Inc. (PBIO) (''PBI'' or the ''Company''), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that its ultra high pressure product line of instruments, methods, and technology platforms was prominently featured at the recent Institute of Food Technologists (''IFT'') annual meeting in Chicago, IL. The Company's Ultra Shear Technology (''UST'') platform, particularly its U.S. Department of Agriculture-funded collaborative program with The Ohio State University's College of Food, Agricultural, and Environmental Sciences, was the focus of much discussion during the four-day conference.

  • ACCESSWIRE3 months ago

    Pressure BioSciences Announces Commercial Release of the HUB880 Explorer

    SOUTH EASTON, MA / ACCESSWIRE / September 13, 2018 / Pressure BioSciences, Inc. (PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced the sale of the first two instruments from its newest line of high-pressure based instrument systems, the HUB880 Explorer. Dr. Nate Lawrence, PBI's Vice President of Marketing and Sales, said: "We are delighted that the first customer for our new HUB880 Explorer system is one of Japan's leading research institutes conducting research and development on agriculture and food. Dr. Lawrence continued: "We are equally pleased that the second system was recently purchased by the Public Health Microbiology Laboratory ("PHM Laboratory") at Tennessee State University ("TSU").

  • ACCESSWIRE4 months ago

    Pressure BioSciences Awarded Key U.S. Patent for Novel High-Pressure Flow-Through Microfluidic Sample Preparation Device

    Invention Opens Path for Integration of Automated ''Hands-Free'' Sample Prep Workflows Utilizing Company's Patented High-Pressure Platform Technologies SOUTH EASTON, MA / ACCESSWIRE / August 30, 2018 / ...

  • ACCESSWIRE4 months ago

    Pressure BioSciences, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update

    Major Debt to Equity Conversions, Increasing Revenues, and a Significant Operating Loss Decrease Highlight the 2018 Second Quarter Investor Conference Call Scheduled for Wednesday, August 15, 2018 at 4:30 ...

  • ACCESSWIRE4 months ago

    Pressure BioSciences, Inc. to Discuss Second Quarter 2018 Financial Results and Provide Business Update

    SOUTH EASTON, MA / ACCESSWIRE / August 10, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (''PBI'' and the ''Company'') today announced that the Company will host a teleconference to discuss its Second ...

  • ACCESSWIRE5 months ago

    Pressure BioSciences Developing Potential Breakthrough Processing Method for High Quality, Shelf Stable Milk and Other Dairy Products

    SOUTH EASTON, MA / ACCESSWIRE / July 19, 2018 / Pressure BioSciences, Inc. (PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, today announced a major collaboration with the College of Food, Agricultural, and Environmental Sciences of The Ohio State University ("Ohio State"). The primary goal of the program is to develop and make available for commercialization a continuous-flow manufacturing technology that will prepare liquid foods and beverages with preservation of superior sensory and nutritional qualities, while delivering long, room temperature shelf stability without requiring refrigeration or chemical additives throughout the chain of distribution and retail sale. PBI believes achievement of this long sought-after consumer demand can now be accomplished through scale-up of the Company's innovative and patented Ultra Shear Technology ("UST").

  • ACCESSWIRE5 months ago

    Ohio State Scientists Studying Healthier Food and Beverage Processing Options

    COLUMBUS, OH / ACCESSWIRE / July 12, 2018 / The Ohio State University ("Ohio State") today announced that a team of scientists from Ohio State's College of Food, Agricultural, and Environmental Sciences (CFAES) has been awarded a four-year, $891,000 grant from the U.S. Department of Agriculture's National Institute of Food and Agriculture. Health-conscious consumers want great tasting, healthy drinks that don't include chemical additives and preservatives with names they can't pronounce. With financial support from the USDA grant and technical support from Ohio State's collaborators at Pressure BioSciences, Inc. (PBIO), CFAES researchers are seeking to remedy that issue.

  • ACCESSWIRE6 months ago

    Pressure BioSciences Converts Additional $7.24M of Debt into Equity: Total Conversions Exceed $13.6M in Past 30 Days

    SOUTH EASTON, MA / ACCESSWIRE / June 12, 2018 / Pressure BioSciences, Inc. (PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform solutions to the worldwide life sciences industry, today announced the conversion of an additional $7.24M of debt into equity, bringing the total amount of debt that has converted into equity over the past four weeks to over $13.6M. Mr. Joseph L. Damasio, VP of Finance and CFO of PBI, said, "With today's announced conversion of an additional $7.24M of debt to equity, total loan debt has been reduced from approximately $16.6M to approximately $3.0M, which is a level we believe the Company can manage. Mr. Richard T. Schumacher, President and CEO of PBI, expanded, "Over the past few years, we have successfully accessed debt for working capital, which has allowed us to increase revenue, enlarge our customer base, enhance our instrument and consumables line, expand our sales and marketing reach, add much needed manufacturing and development space, and strengthen other internal operational areas.

  • ACCESSWIRE7 months ago

    Pressure BioSciences, Inc. Reports First Quarter 2018 Financial Results and Provides Business Update

    - Total Revenue, Products & Services Revenue, Instrument and Consumable Sales All Increased Y/Y; BaroFold IP Acquisition, Collaborations, Expanded Sales Team Expected to Fuel Growth. - Company Announces ...

  • ACCESSWIRE7 months ago

    Pressure BioSciences, Inc. to Discuss First Quarter 2018 Financial Results and Provide Business Update

    SOUTH EASTON, MA / ACCESSWIRE / May 15, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (''PBI'' and the ''Company'') today announced that the Company will host a teleconference to discuss its First Quarter ...